STRO vs WDAY · rev $62.0M vs P/E 135, rev $8.45B
Sutro Biopharma (STRO) versus Workday Inc (WDAY) — a side-by-side from cached financials, not a winner call.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Workday Inc (WDAY) is a software - application company listed on US.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
Latest reported WDAY revenue for 2025-01-31 was $8.45B. Net income was $526.0M. Revenue was up 16.4% from 2024-01-31 to 2025-01-31. WDAY currently screens at market cap $64.45B and trailing P/E 135.1.
STRO currently screens at market cap $470.8M. WDAY currently screens at market cap $64.45B and trailing P/E 135.1.
Not investment advice. Open the STRO and WDAY stock pages for the full models.
Not investment advice.